Their study shows that liraglutide attached to metformin with high efficacy improves insulin action, weight loss, reduces abdominal obesity, reduces mean glucose levels in the oral glucose tolerance test, and improves lipid profile, compared to metformin used alone in the treatment of postpartum overweight patients with GDM [42]. The gene discussed is INS; the disease is gestational diabetes.